April 20,2020: "Five projects from across Oxford University's Medical Sciences Division are amongst twenty-one new studies into the novel coronavirus which have been funded...
April 20, 2020: "Alembic Pharmaceuticals Limited (Alembic) announced it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated...
April 20, 2020: “Bristol-Myers Squibb announced
that CheckMate -743, a pivotal Phase 3 trial evaluating Opdivo ® (nivolumab)
in combination with Yervoy ® (ipilimumab) in
previously untreated malignant pleural mesothelioma (MPM) met its primary
endpoint...
April 20, 2020: "Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that interim data from...
April 20, 2020: "Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer announces that it has in-licenced exclusive...
April 20, 2020: “Detecting iron deficiency early during pregnancy and in young children is crucial. Iron deficiency in children under two years of age...
April 17, 2020: "Sanofi will host a scientific session to present detailed data from their Phase 2b trial evaluating its investigational BTK (Bruton’s tyrosine...
April 20, 2020: Novartis has entered
an agreement with the US FDA to conduct a Phase III clinical trial of
hydroxychloroquine to treat hospitalised patients with...
April 20, 2020: "A multi-site project, called ‘What’s the STORY?’ has received funding from UK Research and Innovation (UKRI) to assess no vel coronavirus...
April 17, 2020: "The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical...